Also this trial has no relevance to sales. It's purely to support the use of this product and will just add ammunition to the sales force once it is done.
No reason to fret.
Ann: FDA feedback on Pivotal Protocol, page-12
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.37 |
Change
0.095(4.19%) |
Mkt cap ! $1.615B | |||
| Open | High | Low | Value | Volume |
| $2.33 | $2.38 | $2.29 | $2.991M | 1.277M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 39 | 37601 | $2.36 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.37 | 9309 | 25 |
View Market Depth
| Last trade - 14.46pm 26/06/2024 (20 minute delay) ? |
| PNV (ASX) Chart |